Insuk Sohn - Publications

Affiliations: 
Statistics Korea University, Seoul, South Korea 

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Oh JH, Jang SJ, Kim J, Sohn I, Lee JY, Cho EJ, Chun SM, Sung CO. Spontaneous mutations in the single gene represent high tumor mutation burden. Npj Genomic Medicine. 5: 33. PMID 32821429 DOI: 10.1038/S41525-019-0107-6  0.31
2020 Kim JY, Jung HH, Sohn I, Woo SY, Cho H, Cho EY, Lee JE, Kim SW, Nam SJ, Park YH, Ahn JS, Im YH. Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer. Breast Cancer Research and Treatment. PMID 32812178 DOI: 10.1007/S10549-020-05874-1  0.319
2020 Kim KH, Kim J, Park H, Kim H, Lee SH, Sohn I, Lee HY, Park WY. Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification of non-small cell lung carcinoma patients. Thoracic Cancer. PMID 32700470 DOI: 10.1111/1759-7714.13568  0.326
2020 Kim H, Jeong H, Yamaguchi M, Sohn I, Yoon SE, Byeon S, Hur JY, Koh Y, Yoon SS, Kim EJ, Oguchi M, Miyazaki K, Taguchi S, Yoon DH, Cho J, et al. Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma. Blood. PMID 32584959 DOI: 10.1182/Blood.2020005026  0.31
2020 Yu JI, Park HC, Yoo GS, Paik SW, Choi MS, Kim HS, Sohn I, Nam H. Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma. Cancers. 12. PMID 32455607 DOI: 10.3390/Cancers12051300  0.327
2020 Yoon HJ, Kang J, Park H, Sohn I, Lee SH, Lee HY. Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles. Plos One. 15: e0231227. PMID 32251447 DOI: 10.1371/Journal.Pone.0231227  0.33
2019 Bak SH, Park H, Sohn I, Lee SH, Ahn MJ, Lee HY. Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer. Scientific Reports. 9: 8730. PMID 31217441 DOI: 10.1038/S41598-019-45117-Y  0.352
2018 Cho JK, Kim MW, Choi IS, Moon UY, Kim MJ, Sohn I, Kim S, Jeong HS. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study. Bmc Cancer. 18: 969. PMID 30309318 DOI: 10.1186/S12885-018-4876-6  0.315
2018 Lee SW, Park H, Lee HY, Sohn I, Lee SH, Kang J, Sun JM, Ahn MJ. Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach. Scientific Reports. 8: 8968. PMID 29895834 DOI: 10.1038/S41598-018-27273-9  0.345
2018 Lee G, Park H, Sohn I, Lee SH, Song SH, Kim H, Lee KS, Shim YM, Lee HY. Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication. The Oncologist. PMID 29622699 DOI: 10.1634/Theoncologist.2017-0538  0.309
2018 Kim M, Kang TW, Cha DI, Kim YK, Kim SH, Jang KT, Han IW, Sohn I. Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters. Clinical Radiology. PMID 29519500 DOI: 10.1016/J.Crad.2018.01.016  0.314
2018 Bae J, Shin IS, Min YW, Sohn I, Ahn JH, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ. Endoscopic prediction model for differentiating upper submucosal invasion (< 200 μm) and beyond in superficial esophageal squamous cell carcinoma. Oncotarget. 9: 9156-9165. PMID 29507680 DOI: 10.18632/Oncotarget.23900  0.302
2018 Shim J, Hwang C, Jeong S, Sohn I. Semivarying coefficient least-squares support vector regression for analyzing high-dimensional gene-environmental data Journal of Applied Statistics. 45: 1370-1381. DOI: 10.1080/02664763.2017.1371676  0.304
2018 Bak SH, Park H, Sohn I, Lee HY, Lee SH, Ahn M. P2.01-10 Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.1064  0.331
2016 Lee H, Lee J, Sohn I, Park SH, Park JO, Park YS, Kim KM, Kang WK, Kim ST. To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients. Journal of Cancer. 7: 2173-2178. PMID 27994652 DOI: 10.7150/Jca.16551  0.362
2016 Song SH, Park H, Lee G, Lee HY, Sohn I, Kim HS, Lee SH, Jeong JY, Kim J, Lee KS, Shim YM. Imaging phenotyping using radiomics to predict micropapillary pattern within lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27923715 DOI: 10.1016/J.Jtho.2016.11.2230  0.308
2016 Paik ES, Sohn I, Baek SY, Shim M, Choi HJ, Kim TJ, Choi CH, Lee JW, Kim BG, Lee YY, Bae DS. Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pre-treatment Complete Blood Cell Counts in Epithelial Ovarian Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27669704 DOI: 10.4143/Crt.2016.282  0.317
2016 Huh JW, Kim SC, Sohn I, Jung SH, Kim HC. Serum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation. Oncotarget. PMID 26908450 DOI: 10.18632/Oncotarget.7488  0.337
2015 Yoon HJ, Sohn I, Cho JH, Lee HY, Kim JH, Choi YL, Kim H, Lee G, Lee KS, Kim J. Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach. Medicine. 94: e1753. PMID 26469915 DOI: 10.1097/Md.0000000000001753  0.312
2015 Ha SY, Sohn I, Hwang SH, Yang JW, Park CK. The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients. Oncotarget. PMID 26093092 DOI: 10.18632/Oncotarget.4330  0.308
2015 Lee KH, Lee JK, Choi DW, Do IG, Sohn I, Jang KT, Jung SH, Heo JS, Choi SH, Lee KT. Postoperative Prognosis Prediction of Pancreatic Cancer With Seven MicroRNAs. Pancreas. 44: 764-8. PMID 25906450 DOI: 10.1097/Mpa.0000000000000346  0.308
2015 Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, Ye XS, Do IG, Liu S, Gong L, Fu J, ... ... Sohn I, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature Medicine. 21: 449-56. PMID 25894828 DOI: 10.1038/Nm.3850  0.354
2015 Lee JY, Lim SH, Lee MY, Kim H, Kim M, Kim S, Jung HA, Sohn I, Gil WH, Lee JE, Kim SW, Nam SJ, Ahn JS, Im YH, Park YH. Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25622590 DOI: 10.4143/Crt.2014.168  0.329
2015 Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim KM, Sohn I, Jung SH, Choi MG, Lee JH, Bae JM, Kim S, Kim ST, Park JO, Park YS, et al. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 25559811 DOI: 10.1200/Jco.2014.58.3930  0.306
2015 Park YH, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery. International Journal of Cancer. Journal International Du Cancer. 136: 1976-84. PMID 25537444 DOI: 10.1002/Ijc.29233  0.386
2015 Park YH, Jung HH, Do I, Cho EY, Sohn I, Jung S, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im Y. Abstract P3-06-20: A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers (TNBCs) who receive adjuvant chemotherapy following curative surgery of the primary breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-06-20  0.373
2014 Sung CO, Sohn I. The expression pattern of 19 genes predicts the histology of endometrial carcinoma. Scientific Reports. 4: 5174. PMID 24894155 DOI: 10.1038/Srep05174  0.367
2014 Lee J, Sohn I, Do IG, Kim KM, Park SH, Park JO, Park YS, Lim HY, Sohn TS, Bae JM, Choi MG, Lim do H, Min BH, Lee JH, Rhee PL, et al. Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery. Plos One. 9: e90133. PMID 24598828 DOI: 10.1371/Journal.Pone.0090133  0.362
2014 Sung CO, Song IH, Sohn I. A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19. Gynecologic Oncology. 132: 343-50. PMID 24321399 DOI: 10.1016/J.Ygyno.2013.11.036  0.364
2014 Kim SJ, Sohn I, Do IG, Jung SH, Ko YH, Yoo HY, Paik S, Kim WS. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay. Annals of Hematology. 93: 437-47. PMID 23975159 DOI: 10.1007/S00277-013-1884-0  0.359
2013 Kim J, Sohn I, Kim DD, Jung SH. SNP selection in genome-wide association studies via penalized support vector machine with MAX test. Computational and Mathematical Methods in Medicine. 2013: 340678. PMID 24174989 DOI: 10.1155/2013/340678  0.301
2013 Lee YY, Kim TJ, Kim JY, Choi CH, Do IG, Song SY, Sohn I, Jung SH, Bae DS, Lee JW, Kim BG. Genetic profiling to predict recurrence of early cervical cancer. Gynecologic Oncology. 131: 650-4. PMID 24145113 DOI: 10.1016/J.Ygyno.2013.10.003  0.336
2013 Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Annals of Surgical Oncology. 20: 3747-53. PMID 23800896 DOI: 10.1245/S10434-013-3070-Y  0.36
2013 Park JY, Nam JH, Kim YT, Kim YM, Kim JH, Kim DY, Sohn I, Lee SW, Sung CO, Kim KR. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients. Virchows Archiv : An International Journal of Pathology. 462: 289-96. PMID 23417747 DOI: 10.1007/S00428-013-1382-8  0.339
2013 Lee SJ, Do IG, Lee J, Kim KM, Jang J, Sohn I, Kang WK. Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors. Targeted Oncology. 8: 271-80. PMID 23371028 DOI: 10.1007/S11523-013-0253-1  0.341
2013 Sohn I, Sung CO. Predictive modeling using a somatic mutational profile in ovarian high grade serous carcinoma. Plos One. 8: e54089. PMID 23326577 DOI: 10.1371/Journal.Pone.0054089  0.311
2012 Sohn I, Jung WY, Sung CO. Somatic hypermutation and outcomes of platinum based chemotherapy in patients with high grade serous ovarian cancer. Gynecologic Oncology. 126: 103-8. PMID 22484402 DOI: 10.1016/J.Ygyno.2012.03.050  0.369
2012 Kim ST, Uhm JE, Lee J, Sun JM, Sohn I, Kim SW, Jung SH, Park YH, Ahn JS, Park K, Ahn MJ. Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy. Lung Cancer (Amsterdam, Netherlands). 75: 82-8. PMID 21684626 DOI: 10.1016/J.Lungcan.2011.05.022  0.309
2012 Kim J, Sohn I, Jung SH, Kim S, Park C. Analysis of survival data with group lasso Communications in Statistics: Simulation and Computation. 41: 1593-1605. DOI: 10.1080/03610918.2011.611311  0.332
2011 Sohn I, Owzar K, Lim J, George SL, Mackey Cushman S, Jung SH. Multiple testing for gene sets from microarray experiments. Bmc Bioinformatics. 12: 209. PMID 21615889 DOI: 10.1186/1471-2105-12-209  0.306
2010 Sohn I, Owzar K, George SL, Kim S, Jung SH. Robust test method for time-course microarray experiments. Bmc Bioinformatics. 11: 391. PMID 20649954 DOI: 10.1186/1471-2105-11-391  0.307
2010 Augustine CK, Jung SH, Sohn I, Yoo JS, Yoshimoto Y, Olson JA, Friedman HS, Ali-Osman F, Tyler DS. Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. Molecular Cancer Therapeutics. 9: 779-90. PMID 20371714 DOI: 10.1158/1535-7163.Mct-09-0764  0.343
2010 Kim DH(, Han B, Lee K, Ahn T, Son D, Sohn I, Jung S, Park K, Jang JH, Kim K, Kim HJ, Sohn SK, Moon JH, Kim J, Huh N, et al. Pharmacogenomics-Based Drug Response Prediction Model for Acute Myeloid Leukemia with Normal Karyotype Blood. 116: 2698-2698. DOI: 10.1182/Blood.V116.21.2698.2698  0.303
2009 Sohn I, Owzar K, George SL, Kim S, Jung SH. A permutation-based multiple testing method for time-course microarray experiments. Bmc Bioinformatics. 10: 336. PMID 19832992 DOI: 10.1186/1471-2105-10-336  0.304
2009 Sohn I, Kim J, Jung SH, Park C. Gradient lasso for Cox proportional hazards model Bioinformatics. 25: 1775-1781. PMID 19447787 DOI: 10.1093/Bioinformatics/Btp322  0.337
2009 Sohn I, Shim J, Hwang C, Kim S, Lee JW. Informative transcription factor selection using support vector machine-based generalized approximate cross validation criteria Computational Statistics & Data Analysis. 53: 1727-1735. DOI: 10.1016/J.Csda.2008.05.001  0.312
2009 Shim J, Sohn I, Kim S, Lee JW, Green PE, Hwang C. Selecting marker genes for cancer classification using supervised weighted kernel clustering and the support vector machine Computational Statistics and Data Analysis. 53: 1736-1742. DOI: 10.1016/J.Csda.2008.04.028  0.336
2008 Owzar K, Barry WT, Jung SH, Sohn I, George SL. Statistical challenges in preprocessing in microarray experiments in cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5959-66. PMID 18829474 DOI: 10.1158/1078-0432.Ccr-07-4532  0.333
2006 Koo J, Sohn I, Kim S, Lee JW. Structured polychotomous machine diagnosis of multiple cancer types using gene expression Bioinformatics. 22: 950-958. PMID 16452113 DOI: 10.1093/Bioinformatics/Btl029  0.35
Show low-probability matches.